YTHDC1

YTH N6-methyladenosine RNA binding protein C1, the group of YTH domain containing N6-methyladenosine readers

Basic information

Region (hg38): 4:68310387-68350090

Links

ENSG00000083896NCBI:91746OMIM:617283HGNC:30626Uniprot:Q96MU7AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • autism spectrum disorder (Limited), mode of inheritance: AD

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the YTHDC1 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the YTHDC1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
24
clinvar
1
clinvar
25
nonsense
0
start loss
0
frameshift
0
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 24 2 0

Variants in YTHDC1

This is a list of pathogenic ClinVar variants found in the YTHDC1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
4-68314109-T-A not specified Uncertain significance (Oct 26, 2021)2226230
4-68314127-C-T not specified Uncertain significance (Jul 20, 2022)2376535
4-68314134-T-C not specified Uncertain significance (Sep 17, 2021)2251309
4-68314187-C-T not specified Uncertain significance (Oct 03, 2022)2314942
4-68314262-C-T not specified Uncertain significance (Mar 01, 2023)2492004
4-68318532-G-A not specified Uncertain significance (May 10, 2024)3333727
4-68318841-T-C not specified Uncertain significance (Mar 07, 2024)3191637
4-68318860-A-G not specified Uncertain significance (Jul 15, 2021)2383352
4-68320129-T-C not specified Uncertain significance (Jun 29, 2023)2608906
4-68322785-C-T not specified Uncertain significance (Jan 24, 2024)3191635
4-68332188-C-T not specified Uncertain significance (Mar 19, 2024)3333729
4-68332838-T-C not specified Uncertain significance (Aug 08, 2022)2306226
4-68337089-C-T not specified Likely benign (Jun 28, 2022)2298315
4-68337153-C-T not specified Uncertain significance (Sep 27, 2022)2409435
4-68337208-TTCC-T YTHDC1-related disorder Likely benign (Apr 25, 2023)3053679
4-68337242-T-C not specified Uncertain significance (Jan 04, 2022)2269712
4-68337328-T-A not specified Uncertain significance (Nov 12, 2021)2261212
4-68337344-C-T not specified Uncertain significance (Mar 18, 2024)3333728
4-68337614-A-T not specified Uncertain significance (Sep 12, 2023)2591715
4-68337624-C-T not specified Uncertain significance (May 26, 2023)2519603
4-68337642-G-A not specified Uncertain significance (Nov 08, 2022)2223074
4-68337654-T-C not specified Uncertain significance (Jul 12, 2022)2384357
4-68337693-C-T not specified Uncertain significance (Sep 22, 2022)2396618
4-68337774-C-T not specified Uncertain significance (May 09, 2022)2288249
4-68337825-A-G not specified Uncertain significance (Oct 27, 2023)3191638

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
YTHDC1protein_codingprotein_codingENST00000344157 1739703
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.005.76e-8125734021257360.00000795
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.482694100.6560.00002304750
Missense in Polyphen2375.9370.30288879
Synonymous-0.3551351301.040.000006261326
Loss of Function6.46150.50.01980.00000353543

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00001780.0000176
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Regulator of alternative splicing that specifically recognizes and binds N6-methyladenosine (m6A)-containing RNAs (PubMed:26318451, PubMed:26876937, PubMed:25242552, PubMed:28984244). M6A is a modification present at internal sites of mRNAs and some non-coding RNAs and plays a role in the efficiency of mRNA splicing, processing and stability (PubMed:26318451, PubMed:25242552). Acts as a key regulator of exon-inclusion or exon-skipping during alternative splicing via interaction with mRNA splicing factors SRSF3 and SRSF10 (PubMed:26876937). Specifically binds m6A-containing mRNAs and promotes recruitment of SRSF3 to its mRNA-binding elements adjacent to m6A sites, leading to exon-inclusion during alternative splicing (PubMed:26876937). In contrast, interaction with SRSF3 prevents interaction with SRSF10, a splicing factor that promotes exon skipping: this prevents SRSF10 from binding to its mRNA-binding sites close to m6A-containing regions, leading to inhibit exon skipping during alternative splicing (PubMed:26876937). May also regulate alternative splice site selection (PubMed:20167602). Also involved in nuclear export of m6A-containing mRNAs via interaction with SRSF3: interaction with SRSF3 facilitates m6A-containing mRNA-binding to both SRSF3 and NXF1, promoting mRNA nuclear export (PubMed:28984244). Also recognizes and binds m6A on other RNA molecules (PubMed:27602518). Involved in random X inactivation mediated by Xist RNA: recognizes and binds m6A-containing Xist and promotes transcription repression activity of Xist (PubMed:27602518). Involved in S- adenosyl-L-methionine homeostasis by regulating expression of MAT2A transcripts, probably by binding m6A-containing MAT2A mRNAs (By similarity). {ECO:0000250|UniProtKB:E9Q5K9, ECO:0000269|PubMed:20167602, ECO:0000269|PubMed:25242552, ECO:0000269|PubMed:26318451, ECO:0000269|PubMed:26876937, ECO:0000269|PubMed:27602518, ECO:0000269|PubMed:28984244}.;

Recessive Scores

pRec
0.126

Intolerance Scores

loftool
rvis_EVS
-0.58
rvis_percentile_EVS
18.59

Haploinsufficiency Scores

pHI
0.252
hipred
Y
hipred_score
0.729
ghis
0.686

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.967

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ythdc1
Phenotype
endocrine/exocrine gland phenotype; cellular phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Gene ontology

Biological process
mRNA splice site selection;mRNA export from nucleus;dosage compensation by inactivation of X chromosome;posttranscriptional regulation of gene expression;regulation of mRNA splicing, via spliceosome
Cellular component
nucleus;nucleoplasm;plasma membrane;nuclear speck
Molecular function
RNA binding;protein binding;N6-methyladenosine-containing RNA binding